Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HPTC Versus AFSM in Diabetic Foot Ulcers

NCT: NCT07781917 · NOT_YET_RECRUITING

NCT IDNCT07781917
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2027-03
SponsorAdichunchanagiri Institute of Medical Sciences, B G Nagara (OTHER)
First posted
Last updated

Brief Summary

This is a randomized controlled clinical investigation in patients suffering from diabetic foot ulcers at multiple centres in India and Bangladesh. The study compares patient outcomes using standard wound care with a High Purity Type-I Collagen-Based Skin Substitute against standard wound care with an Acellular Intact Fish Skin Matrix.

Frequently Asked Questions

What is HPTC Versus AFSM in Diabetic Foot Ulcers?

HPTC Versus AFSM in Diabetic Foot Ulcers is a clinical trial registered under NCT07781917. Current status: NOT_YET_RECRUITING.

What is the status of NCT07781917?

The current status of NCT07781917 (HPTC Versus AFSM in Diabetic Foot Ulcers) is: NOT_YET_RECRUITING.

When did HPTC Versus AFSM in Diabetic Foot Ulcers start?

HPTC Versus AFSM in Diabetic Foot Ulcers started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑